Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19

• Published in: Hepatology (Baltimore, Md.) Vol. 74; no. 4; pp. 1750 - 1765
• Main Authors: Yip, Terry Cheuk‐Fung, Wong, Vincent Wai‐Sun, Lui, Grace Chung‐Yan, Chow, Viola Chi‐Ying, Tse, Yee‐Kit, Hui, Vicki Wing‐Ki, Liang, Lilian Yan, Chan, Henry Lik‐Yuen, Hui, David Shu‐Cheong, Wong, Grace Lai‐Hung
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.10.2021; John Wiley and Sons Inc
• Subjects: Acute Lung Injury - blood; Acute Lung Injury - diagnosis; Acute Lung Injury - epidemiology; Acute Lung Injury - virology; Adult; Age Factors; Aged; Alanine; Alanine Transaminase; Aspartate aminotransferase; Aspartate Aminotransferases; Bilirubin; Cardiovascular diseases; Cirrhosis; Corticosteroids; COVID-19; COVID-19 - complications; COVID-19 - diagnosis; COVID-19 - mortality; COVID-19 - virology; Diabetes mellitus; Female; Hepatitis B surface antigen; Hepatitis B Surface Antigens - isolation & purification; Hepatitis B virus - immunology; Hepatitis B virus - isolation & purification; Hepatitis B, Chronic - complications; Hepatitis B, Chronic - diagnosis; Hepatitis B, Chronic - epidemiology; Hepatitis B, Chronic - virology; Hepatitis C; Hepatology; Hong Kong - epidemiology; Humans; Infections; Liver; Liver cirrhosis; Lopinavir; Male; Medical History Taking - statistics & numerical data; Middle Aged; Mortality; Original; Retrospective Studies; Ribavirin; Risk Assessment - statistics & numerical data; Risk Factors; Ritonavir; Hong Kong

Background and Aims We compared risk of acute liver injury and mortality in patients with COVID‐19 and current, past, and no HBV infection. Approach and Results This was a territory‐wide retrospective cohort study in Hong Kong. Patients with COVID‐19 between January 23, 2020, and January 1, 2021, we...